Bcr-Abl inhibitor CHMFL-ABL-039, Purity ≥98%

Synonym: 2304344-56-5; Bcr-Abl inhibitor

Product Size

1 mg; 5 mg; 10 mg; 25 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

CHMFL-ABL-039 specifically inhibits the activity of the Bcr-Abl tyrosine kinase.

Molecular Weight

594.63

Molecular Formula

C₃₁H₃₃F₃N₆O₃

Form

Lyophilized powder

Purity

≥98%

Identity

Confirmed by NMR/HPLC/MS.

Applications

CHMFL-ABL-039 is studied for its potential to inhibit the Bcr-Abl fusion protein, offering a pathway to manage chronic myeloid leukemia.